Literature DB >> 3495571

Regulation of interleukin 1 gene expression by adherence and lipopolysaccharide.

R C Fuhlbrigge, D D Chaplin, J M Kiely, E R Unanue.   

Abstract

Murine peritoneal exudate cells (PEC), analyzed immediately after isolation, did not express detectable IL 1 activity or IL 1-specific mRNA. Stimulation of these cells by adherence induced the expression of intracellular, membrane, and extracellular IL 1 activities within 4 hr. Analysis of mRNA from these cells showed a concurrent induction of both IL 1 alpha and IL 1 beta mRNA within 1 hr. However, this stimulation of IL 1 expression was transient, since PEC cultured for 5 days no longer expressed IL 1 bioactivity or specific mRNA. Stimulation of these quiescent cells with bacterial lipopolysaccharide induced the re-expression of intracellular, membrane, and extracellular IL 1 activities as well as IL 1 alpha and IL 1 beta mRNA. We found no qualitative difference in the degree or rate of induction of IL 1 alpha compared with IL 1 beta mRNA. These results indicate that resting macrophages are IL 1 negative, and that the IL 1 inducing stimuli used in this study act transiently to increase the levels of IL 1 alpha and IL 1 beta mRNA.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3495571

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  Activation of human monocytes/macrophages by hypo-osmotic shock.

Authors:  O Frenkel; E Shani; I Ben-Bassat; F Brok-Simoni; E Shinar; D Danon
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  Activation of human monocytes for enhanced production of interleukin 8 during transendothelial migration in vitro.

Authors:  M Takahashi; U Ikeda; T Kasahara; S Kitagawa; Y Takahashi; K Shimada; S Kano; C Morimoto; J Masuyama
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

3.  Collagen-induced release of interleukin 1 from human blood mononuclear cells. Potentiation by fibronectin binding to the alpha 5 beta 1 integrin.

Authors:  R Pacifici; C Basilico; J Roman; M M Zutter; S A Santoro; R McCracken
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

4.  Expression of membrane interleukin 1 by fibroblasts transfected with murine pro-interleukin 1 alpha cDNA.

Authors:  R C Fuhlbrigge; S M Fine; E R Unanue; D D Chaplin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

5.  Release of interleukin 1 inhibitory activity (contra-IL-1) by human monocyte-derived macrophages infected with human immunodeficiency virus in vitro and in vivo.

Authors:  R M Locksley; S Crowe; M D Sadick; F P Heinzel; K D Gardner; M S McGrath; J Mills
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

6.  Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human blood-derived monocyte-macrophages.

Authors:  R M Benson; L M Minter; B A Osborne; E V Granowitz
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

7.  Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats.

Authors:  R B Kimble; J L Vannice; D C Bloedow; R C Thompson; W Hopfer; V T Kung; C Brownfield; R Pacifici
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

8.  Interaction of the cell-binding domain of fibronectin with VLA-5 integrin induces monokine production in cultured human monocytes.

Authors:  T Takizawa; S Nishinarita; N Kitamura; J Hayakawa; H Kang; Y Tomita; K Mitamura; K Yamagami; T Horie
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

9.  Adherence status regulates the primary cellular activation responses to the flavivirus West Nile.

Authors:  J Shen; J M Devery; N J King
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

10.  An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines.

Authors:  A R Nusrat; H A Chapman
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.